Candesartan as an Adjunctive Treatment for Bipolar Depression

Summary

This study will assess the safety and tolerability of Candesartan when used in patients with Bipolar Disorder, in addition to their medication treatment.

Timeline

Start

2020-10-01

Primary completion

2022-07-01

Completion

2022-09-01

Outcome

Outcome not reported

Stopped (Business): “The reason the study was withdrawn was due to lack of funds. In addition, the PI is moving to a different institution and it would not be feasible to proceed with the study under these circumstances.”

Drugs

Indications